Patron Law Firms
Jayne Conroy
| Hanly Conroy Bierstein Sheridan Fisher Hayes, LLP | |
| MTTLA Executive Board Member | |
| Hanly Conroy | |
| New York, New York | |
| Born Woburn, Massachusetts, March 29, 1958. Admitted to bar: 1985, Massachusetts; 1986, U.S. District Court, District of Massachusetts and U.S. Court of Appeals, First Circuit; 1996, District of Columbia; 1997, New York and U.S. District Court, Southern and Eastern Districts of New York; 2003, U.S. District Court, District of Columbia and U.S. Court of Federal Claims; 2004, U.S. District Court, Southern District of Illinois. Education: Dartmouth College (B.A., 1980); New England School of Law (J.D., 1985). Editor, New England Journal on Criminal & Civil Confinement, 1984-85. Member: The Association of the Bar of the City of New York; New York State (Chair, Products Liability Committee, 2002 to date) and Massachusetts Bar Associations; Federal Bar Council (Panelist on Trial Advocacy, Winter Bench & Bar Conference, 2001, 2003); New York County Lawyers Association (CLE Instructor on Trial Advocacy 2000, 2001); American Association for Justice; Co-Chair, Mealey's Asbestos and Bankruptcy Seminar (2001); Lecturer, National Law Journal Litigation Summit (2002); Panelist, Mealey’s Pharmaceutical Lawyers’ SuperConference (2008); Panelist, ABA 2008 Pharmaceutical CLE Workshop.
Ms. Conroy is an experienced litigator who enjoys a superb national reputation as a skilled strategist, trial lawyer and negotiator. For many years Ms. Conroy acted as national trial and coordinating defense counsel to a multi-national corporation and several of its subsidiaries. In recent years she has represented plaintiffs exclusively in a wide variety of products liability matters. Currently her practice focuses on plaintiffs’ pharmaceutical actions on behalf of several thousand plaintiffs who were administered the drugs OxyContin, Zelnorm, Zyprexa, Vioxx, Celebrex, Bextra, gadolinium contrast dyes, Ephedra, Chantix, Yazmin and Yaz. Ms. Conroy serves as a member of Plaintiffs’ Steering and Coordinating Committees in several multidistrict pharmaceutical litigations, and is credited with orchestrating the settlements between 2006 and the present of thousands of pharmaceutical cases for a total recovery for the firm’s clients that approaches $200 million. Throughout much of 2008 Ms. Conroy was engaged in negotiating the terms of the landmark, $894 million settlement of Bextra and Celebrex cases against Pfizer. Ms. Conroy has also represented several thousand victims of the September 11, 2001 tragedy in a multi-district action against the financial sponsors of terrorism, and, in a separate set of negligence litigations against the airlines and airport security companies on behalf of 50 families who lost their loved ones on the four 9/11 aircraft, helped to forge settlements that totaled in the hundreds of millions of dollars. On May 14, 2010 Ms. Conroy was appointed to the Lead Counsel Committee for Economic Loss claims in the massive Toyota Unintended Acceleration Cases multi-district litigation pending in federal court in Santa Ana, California. Ms. Conroy is nationally renowned as a speaker on trial advocacy and is regularly invited to sit on panels of experts at national litigation conferences. Representative cases include: • In re Toyota Motor Corp. Unintended Acceleration Marketing, Sales Practices, and Product Liability Litigation, MDL 2151 (C.D. Cal.); • In re Yazmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL 2100 (S.D. Ill.) (court-appointed co-chair Plaintiffs’ Law and Briefing Committee); • In re Chantix (Varenicline) Products Liability Litigation, MDL 2092 (N.D. Ala.) (court-appointed Plaintiff State and Federal Court Co-Liaison); • In re Gadolinium-Based Contrast Agents Products Liability Litigation, MDL 1909 (N.D. Oh.) (court-appointed member of Plaintiffs’ Steering Committee); • In re Zyprexa Litigation, MDL 1596 (E.D.N.Y.) (court-appointed member of Plaintiffs’ Executive Committee); • In re Bextra and Celebrex Products Liability Litigation, MDL 1699 (N.D. Cal.) and New York State Coordinated Proceedings (court-appointed member of Discovery and Science Committees, Trial Team and Common Benefit Allocation Committee); • Owens-Illinois, Inc. v. T&N Ltd. , 191 F.R.D. 522 (E.D. Tex. 2000) (successful vacation of $1.66 billion default judgment); • Chase Manhattan Bank v. T&N plc, 1997 WL 221203 (S.D.N.Y. Apr. 28, 1997), aff'd, 162 F.3d 1147 (2d Cir. 1998) (successful defense of largest asbestos property damage case ever tried in U.S.) (trial profiled in "Chase's Case Turns to Dust," The American Lawyer (May 1996)); and • Prudential Ins. Co. v. T&N plc (D. Mass. 1992) (successful defense verdict). Ms. Conroy resides in New York City and Cape Cod. |
|
 |
